PLUS THERAPEUTICS Inc. share price logo

PLUS THERAPEUTICS Inc.

NASDAQ: PSTV

$3.87

+0.22

(+6.03%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 31 Jul 2026

PLUS THERAPEUTICS Inc. Stock Performance

as on August 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $3.62
    $3.95
    downward going graph

    6.46%

    Downside

    2.07%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.90
    $23.43
    downward going graph

    25.06%

    Downside

    505.30%

    Upside

    downward going graph

PLUS THERAPEUTICS Inc. share price movements today

Previous Close
$3.65
Open
$3.72
Volume
282.3K
Day's Low - High
$3.62 - $3.95
52 Week Low - High
$2.90 - $23.43

PLUS THERAPEUTICS Inc. Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

PLUS THERAPEUTICS Inc. Stock Fundamentals & Key Indicators

Check PLUS THERAPEUTICS Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

PLUS THERAPEUTICS Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PLUS THERAPEUTICS Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
PLUS THERAPEUTICS Inc. image
PLUS THERAPEUTICS Inc.
BUY$-NANA0.00%NA
Revolution Medicines image
Revolution Medicines
BUY$43.7B669.3%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$128.2B154.86%29.8286.04%NA
Regeneron image
Regeneron
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Analyst Recommendation on PLUS THERAPEUTICS Inc. Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for PLUS THERAPEUTICS Inc.. Average target price of $36

PLUS THERAPEUTICS Inc. Share Price Target

Get share price movements and forecasts by analysts on PLUS THERAPEUTICS Inc..

What analysts predicted

89.25%UPSIDE

Target Price

$36

Current Price

$3.87

Analyzed by

10 Analysts

Target

$36.00

PLUS THERAPEUTICS Inc. target price $36, a slight upside of 89.25% compared to current price of $3.87. According to 10 analysts rating.

PLUS THERAPEUTICS Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1
1
1
1
1
1
1
1
1
1
Gross Profit
1
1
1
1
1
0
1
1
1
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-3
-2
-2
-3
-17
5
-4
-5
-6
Net Profit Margin
-290.18%
-194.45%
-229.87%
-197.39%
-276.42%
-1643.15%
370.58%
-316.61%
-417.92%
-675.68%

PLUS THERAPEUTICS Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
11
6
2
6
0
-
0
4
5
5
Gross Profit
8
5
1
6
-2
0
0
-4
4
4
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-22
-22
-12
-10
-8
-13
-20
-13
-12
-22
Net Profit Margin
-193.73%
-353.86%
-423.53%
-155.57%
-2719.80%
0.00%
-9051.34%
-271.04%
-222.84%
-429.43%

Global Institutional Holdings in PLUS THERAPEUTICS Inc.

Funds
Holdings
State Street Corp
0.27%
Scientech Research LLC
0.08%
Citadel Advisors Llc
0.11%
Citigroup Inc
0.05%
Mercer Global Advisors Inc.
0.02%
See all

PLUS THERAPEUTICS Inc. News & Key Events

  • img

    Today's Timeline - 30 June

    Tue, 06:19 PM

    -

    Plus Therapeutics to rebrand as Cerenome and adopt CNSY ticker on August 3, 2026, while affirming 2026 milestone guidance.

Insights on PLUS THERAPEUTICS Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 412.0% return, outperforming this stock by 485.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 488.1% return, outperforming this stock by 582.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, PSTV stock has moved down by -73.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 5.15M → -6.94M (in $), with an average decrease of 78.9% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 1.39M → 1.02M (in $), with an average decrease of 13.5% per quarter

About PLUS THERAPEUTICS Inc.

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. Combining image-guided local beta radiation and targeted drug delivery approaches, it is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). Its lead radiotherapeutic candidate, REYOBIQ (rhenium (186Re) obisbemeda), is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC) by direct localized delivery utilizing approved standard-of-care tissue access such as with convection-enhanced delivery (CED) and intraventricular brain (Ommaya reservoir) catheters. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers including primary and secondary liver cancers via intra-arterial injections.
OrganisationPLUS THERAPEUTICS Inc.
E-voting on sharesClick here to vote

FAQs

What is PLUS THERAPEUTICS Inc. share price today?

PLUS THERAPEUTICS Inc. share price today is $3.87 as on at the close of the market. PLUS THERAPEUTICS Inc. share today touched a day high of $3.95 and a low of $3.62.

What is the 52 week high and 52 week low for PLUS THERAPEUTICS Inc. share?

PLUS THERAPEUTICS Inc. share touched a 52 week high of $23.43 on and a 52 week low of $2.90 on . PLUS THERAPEUTICS Inc. stock price today i.e. is closed at $3.87,which is 83.48% down from its 52 week high and 33.45% up from its 52 week low.

How to invest in PLUS THERAPEUTICS Inc. Stock (PSTV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PLUS THERAPEUTICS Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PLUS THERAPEUTICS Inc. Shares that will get you 0.3876 shares as per PLUS THERAPEUTICS Inc. share price of $3.87 per share as on August 3, 2026 at 8:45 am IST.

What is the minimum amount required to buy PLUS THERAPEUTICS Inc. Stock (PSTV) from India?

Indian investors can start investing in PLUS THERAPEUTICS Inc. (PSTV) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in PLUS THERAPEUTICS Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on PLUS THERAPEUTICS Inc. share’s latest price of $3.87 as on August 3, 2026 at 8:45 am IST, you will get 2.5840 shares of PLUS THERAPEUTICS Inc.. Learn more about fractional shares .